Ellin Febrina
Overview
Explore the profile of Ellin Febrina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
9
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herdiana Y, Febrina E, Nurhasanah S, Gozali D, Elamin K, Wathoni N
Pharmaceutics
. 2024 Aug;
16(8).
PMID: 39204388
Chitosan nanoparticles (CSNPs) are promising vehicles for targeted and controlled drug release. Recognized for their biodegradability, biocompatibility, low toxicity, and ease of production, CSNPs represent an effective approach to drug...
2.
Ramadaini T, Sumiwi S, Febrina E
Drug Des Devel Ther
. 2024 Aug;
18:3595-3616.
PMID: 39156483
Background: Diabetes mellitus is a complex metabolic disorder that has an enormous impact on people's quality of life and health. Although there is no doubt about the effectiveness of oral...
3.
Rohani , Febrina E, Wahyuni I, Levita J
Drug Des Devel Ther
. 2023 Nov;
17:3473-3491.
PMID: 38024536
Dipeptidyl peptidase IV (DPP-IV) is an enzyme responsible for the degradation of the incretin hormone glucagon-like peptide-1 (GLP-1). DPP-IV plays a significant role in regulating blood glucose levels by modulating...
4.
Pradipta I, Ronasih E, Kartikawati A, Hartanto H, Amelia R, Febrina E, et al.
J Family Community Med
. 2015 May;
22(2):101-5.
PMID: 25983606
Context: Irrational use of antibacterial drugs in Community Health-Care Centers (CHCs) may lead to increased resistance, morbidity, and mortality. Aims: The aim of this study was to determine patterns of...